Latest News

Federal Home Loan Mortgage (FMCC) is back on many investors’ screens after a sharp 12.7% decline over the past 3 months and a 7.5% drop over the past month, prompting fresh questions on valuation. See our latest analysis for Federal Home Loan Mortgage. The recent pullback fits into a mixed picture for Federal Home Loan Mortgage, with the share price at US$10.08 after a 7.5% 30 day share price return decline and a very large 3 year total shareholder return. This suggests strong longer term...

In early January 2026, UGI Corporation drew attention as Hamlin Capital Management opened a new US$22.0 million position and Wall Street analysts issued an “Outperform” rating, while the company also managed operational events including a mall gas-odor investigation and ongoing gas main replacement work in Pennsylvania. Together, heightened institutional interest, positive analyst commentary, and visible utility field activity underscore how UGI’s regulated energy footprint and capital...

Alkermes (ALKS) shares are in focus after the U.S. FDA granted Breakthrough Therapy designation to alixorexton for narcolepsy type 1, based on phase 1 and Vibrance-1 phase 2 clinical data. See our latest analysis for Alkermes. At a share price of $29.66, Alkermes has seen a 7 day share price return of 4.95% and a 1 year total shareholder return of 5.63%, suggesting recent momentum after a softer 90 day share price return decline of 4.97% as attention turns to the alixorexton program. If this...

If you are wondering whether N-able's share price around US$7.31 actually reflects its underlying worth, you are not alone. This article is built to help you size that up clearly. Over the past week the stock is roughly flat at a 0.1% return, but that sits against a 4.2% decline over 30 days and a 19.7% decline over the past year, which can change how investors view both its potential and its risks. Recent coverage has focused on how N-able is positioned within the broader software and IT...

If you are looking at Ciena and wondering whether the current share price offers good value or is running ahead of itself, you are not alone. The stock closed at US$230.56, with a 6.3% decline over the last 7 days, a 3.9% gain over the last 30 days, and returns of 180.3% over 1 year, 351.3% over 3 years, and 332.5% over 5 years. This naturally raises questions about growth potential and changing risk perceptions. Recent coverage around Ciena has focused on its position in networking and...

If you are looking at Willis Lease Finance and asking whether the current share price still offers value, you are not alone. The answer depends heavily on how you choose to value the business. The stock last closed at US$155.82, with returns of 16.2% over the past week, 15.7% over the last month, 16.2% year to date, a 24.1% decline over the last year, and a very large gain over the past 5 years. Recent share price moves sit against a backdrop of ongoing interest in aircraft engine leasing...

Alkane Resources Ltd recently reported its third-quarter and half-year 2025 production and sales, delivering 43,663 ounces of gold equivalent in the quarter and maintaining group fiscal 2026 guidance of 160,000 to 175,000 AuEq ounces at an all-in sustaining cost of A$2,600 to A$2,900 per ounce. The company also ended the quarter with A$246,000,000 in cash, bullion, and listed investments, underscoring a strong liquidity position alongside steady production. We’ll explore how Alkane’s...

If you have been wondering whether P10 is priced attractively right now, you are not alone. Many investors are asking the same question about what they are really paying for with this stock. P10 shares last closed at US$10.33, with recent returns of 4.4% over the past week, 1.2% over the past month, 4.4% year to date, and a 17.6% decline over the past year and 7.6% decline over three years. Recent market attention on P10 has been shaped by ongoing discussion around its role in the...

Lojas Quero-Quero S.A. ( BVMF:LJQQ3 ) shareholders should be happy to see the share price up 14% in the last quarter...

Immuneering Corporation recently reported updated Phase 2a data showing encouraging overall survival, response, and safety outcomes for its atebimetinib plus modified gemcitabine/nab-paclitaxel regimen in previously untreated pancreatic cancer patients, and confirmed plans to begin a pivotal Phase 3 trial in mid-2026. A key nuance is that the reported survival benefit is based on comparisons to historical MPACT trial benchmarks rather than a head-to-head control arm, which may influence how...

On 7 January 2026, the World Orphan Drug Alliance and Syndax Pharmaceuticals announced a collaboration to expand global access to Syndax’s first-in-class menin inhibitor Revuforj (revumenib) via a Managed Access Program for eligible patients outside the U.S. where local regulations and funding allow. This partnership broadens real-world use of Revuforj in difficult-to-treat KMT2A-rearranged and NPM1-mutated leukemias, potentially strengthening its clinical footprint beyond the U.S. approval...

In recent days, Tractor Supply has come under fresh scrutiny as Gordon Haskett downgraded the retailer ahead of its January 29, 2026 earnings release, citing softer same‑store sales expectations and limited visibility on long‑term growth targets. This comes as Tractor Supply balances slower revenue expansion, thinner gross margins than peers, and rising viral popularity on social media that is broadening its appeal beyond traditional rural customers. Next, we’ll explore how this downgrade,...

Morningstar, Inc. recently announced that Anne Bramman, a veteran finance leader with more than 30 years of experience across global companies, has been elected to its board of directors and appointed to the Audit and Compensation Committees. Her background as a former CFO and transformation leader in multiple industries positions her to influence Morningstar’s approach to financial oversight, modernization, and capital allocation. We will explore how Bramman’s extensive CFO and audit...

On January 8, 2026, Canadian Utilities Limited declared a first-quarter common share dividend of CA$0.4623 per Class A non-voting and Class B share, alongside a range of Cumulative Redeemable Second Preferred Share dividends, all payable on March 1, 2026 to holders of record as of February 5, 2026. This 1% uplift to the quarterly common dividend, coupled with reaffirmed preferred dividends across multiple series, highlights the company’s emphasis on steady cash returns to shareholders. We’ll...

In 2025, Telstra Group reported strong financial results, including growth in its mobile division, and committed an additional A$800 million over four years to enhance its 5G network coverage and performance. This combination of improved operating metrics and renewed 5G investment focus highlights how Telstra is leaning heavily into network quality as a core competitive advantage. We’ll now examine how Telstra’s additional A$800 million 5G investment commitment could reshape its existing...

If you are wondering whether American Express is fairly priced after a strong run, this article will walk through what the current share price might be implying about future expectations. The stock last closed at US$375.61, with returns of 0.8% over the past week, 0.0% over the past month, 0.8% year to date, 29.4% over the past year and 226.7% over the past five years, which naturally raises questions about how much optimism is already in the price. Recent attention on American Express has...

Eagle Materials (EXP) has drawn fresh attention as investors weigh its recent share performance against fundamentals, including US$2,301.796m in revenue and US$446.799m in net income, alongside its current US$235.66 share price. See our latest analysis for Eagle Materials. The recent 1-day share price return of 6.66% and 7-day share price return of 11.45% point to building momentum, while the 0.75% 1-year total shareholder return and 115.09% 5-year total shareholder return show a much...

If you are wondering whether Bank of Montreal at around $184.56 is offering fair value or a potential bargain, this article will help you frame that question using several valuation angles. The stock has returned 1.6% over the last week, 3.2% over the last month, 1.6% year to date, 37.0% over the last year, 61.8% over three years and 127.8% over five years, which may influence how you think about both opportunity and risk today. Recent coverage has focused on Bank of Montreal as one of...

If you are wondering whether FTAI Aviation's share price still reflects good value after its recent run, you are not alone. The stock most recently closed at US$245.73, with returns of 16.8% over the past week, 34.9% over the past month, 16.8% year to date, 42.6% over the past year and a very large gain over the past 3 years and 5 years. Recent coverage has focused on FTAI Aviation's position within the aviation sector and investor interest in its business model. This has helped keep the...

Why Black Hills’ Ready Wyoming project matters for shareholders Black Hills (BKH) has just completed and energized its 260 mile, $350 million Ready Wyoming electric transmission expansion, linking its South Dakota and Wyoming systems and putting fresh attention on the stock. See our latest analysis for Black Hills. Despite the Ready Wyoming announcement and an upcoming 2025 earnings release in early February, Black Hills’ share price at $70.72 sits on a modest year to date gain of 1.54%,...

Commonwealth Bank of Australia (ASX:CBA) is back in focus after topping Bloomberg’s 2025 Australian bonds and loans league tables. This highlights its role in debt markets as investors watch upcoming data and earnings. See our latest analysis for Commonwealth Bank of Australia. CBA’s recent leadership in bonds and loans sits alongside a softer share price patch, with the latest close at A$153.22 and a 90 day share price return of a 9% decline, even as the 5 year total shareholder return of...

If you are wondering whether Masco's current share price offers real value or just noise, you are not alone. The stock recently closed at US$69.32, with returns of 7.5% over the last 7 days, 9.3% over 30 days, 7.5% year to date and a 2.1% decline over 1 year, alongside 40.9% and 34.9% returns over 3 and 5 years. Recent news flow around Masco has focused on its position in the broader capital goods space and how investors are weighing its long term prospects against shorter term sentiment...

If you are wondering whether Banco Latinoamericano de Comercio Exterior S. A is still attractively priced after its recent run, this article will walk through what the current share price might imply about value. The stock closed at US$43.45, with returns of 26.7% over the past year, even though the last 7 days and 30 days saw returns of a 0.8% decline and a 3.5% decline respectively. Recent interest around BLX has largely centered on its role as a specialist trade finance bank for Latin...

Compass (COMP) has drawn fresh attention after recent trading, with the stock showing sizable moves over the past month and past 3 months, even as the business continues to report a net loss alongside positive revenue growth. See our latest analysis for Compass. That momentum has not been limited to a few strong sessions, with a 90 day share price return of 82.39% and a 1 year total shareholder return of 140.00% pointing to building optimism around Compass’s prospects and risk profile at the...